FDA Sunscreen Updates: What Skincare Brands MUST Know

Stay ahead of the curve with the latest FDA Sunscreen Updates & New Options: What Skincare Brands Need to Know. This video breaks down the critical changes impacting the U.S. sunscreen market, including the addition of Bemotrizinol and the removal of PABA and Trolamine Salicylate. Understand the implications of sunscreens being classified as OTC drugs and the specific FDA order OTC000039.

Learn who is affected, from U.S. sunscreen brands to retailers, and discover the essential action steps for compliance. We cover confirming OTC drug status, using permitted actives, required testing, compliant labeling, and removing restricted ingredients. Get crucial deadlines for Bemotrizinol and other changes. Avoid common regulatory mistakes like 'waterproof' claims and ensure your skincare label meets all FDA requirements. The U.S. sunscreen market is booming, and compliance is key to success. US Brand Launch gives you the regulations, retailers, distributors, and competitor intelligence to launch in the USA: https://usbrandlaunch.com. This content is for educational purposes only and not legal advice.

Chapters:
00:00 FDA Sunscreen Updates
00:10 Bemotrizinol Added
00:21 PABA & Trolamine Salicylate Removed
00:30 Sunscreens are OTC Drugs
00:41 FDA Order OTC000039
00:52 Effective August 9, 2026
01:00 PABA & Trolamine Salicylate Removed
01:08 U.S. Sunscreen Brands Affected
01:19 Retailers Must Comply
01:27 Confirm OTC Drug Status
01:35 Use Permitted Actives Only
01:43 Conduct Required Testing
01:50 Prepare Compliant Labeling
01:58 Remove Restricted Ingredients
02:05 Ensure Full Compliance
02:14 Bemotrizinol Effective Aug 9, 2026
02:22 PABA/Trolamine Salicylate Removed Sep 10, 2026
02:33 Comply with Bemotrizinol Rules Now
02:41 U.S. Sunscreen Market: $13.8B
02:53 5.1% Growth Rate
03:02 Avoid Regulatory Mistakes
03:09 No 'Waterproof' Claims
03:18 Launch Your Brand in the U.S.